Veteran clinical development executive with over two decades of global experience in endocrinology, oncology, immunology, and rare diseases. Successfully led multiple NDA/BLAs, clinical programs, and global regulatory submissions across large pharma and biotech. Skilled in medical affairs strategy, investor communications, and cross-functional leadership. Proven track record in AI integration for trial optimization, real-world evidence generation, and advancing therapeutics from early phase through approval. Strong leadership in medical communications, stakeholder engagement, and scaling high-performing clinical teams.